Two announcements in the span of nine days reflect a significant expansion of federal healthcare fraud enforcement resources. On August 4, DOJ announced expansion of its Northeast Health Care Fraud Strike Force to Philadelphia, marking the fourth geographic expansion in less than a year. Nine days later, on August 13, Assistant Attorney General Colin M. McDonald issued a priorities memorandum for the National Fraud Enforcement Division (the Fraud Division), a new DOJ division announced by President Trump in January 2026 … Read the rest
J.P. Morgan Life Sciences Private Capital has invested in Turbett Surgical, according to a news release.
Turbett, founded in 2013 and based in Henrietta, New York, is a medical equipment company that manufactures mobile sterilization pods and consumable filters for surgical equipment sterilization.
J.P. Morgan Life Sciences Private Capital is the life sciences platform of J.P. Morgan Private Capital. The platform invests in early-stage biotherapeutics and late-stage healthcare companies.
Terms of the investment were not disclosed.
Vance Street Capital has announced its acquisition of Injectech from The West Group (TWG).
Injectech, founded in 1998 and based in Fort Collins, Colorado, is a manufacturer of luer locks, bond-in luers, check valves, tube to tube connectors and spikes for the medical industry.
Vance Street, founded in 2007 and based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with between $ … Read the rest
Share
The Trump administration on Friday notified the Supreme Court that, in its view, a Tennessee law banning the use of puberty blockers and hormone therapy for transgender minors does not violate the Constitution’s guarantee of equal protection. But although that position is a change from the one advanced by the Biden administration when the justices heard oral argument in a challenge to the law in December, the Trump administration nonetheless urged the Supreme Court to go ahead and decide … Read the rest
In 2024, healthcare employers have faced several new challenges and developments regarding traditional labor obligations. Unions are becoming more prominent in healthcare, including by unionizing doctors at unprecedented rates and by becoming more involved in government-funded projects. At the same time, federal agencies are imposing significant new labor obligations on healthcare employers, regardless of whether or not they have unions representing their employees. While the Federal Trade Commission’s non-compete rule has garnered major attention (as we discussed further here and … Read the rest
Loper Bright Shifts Statutory Interpretation Powers Back to the Courts.
On June 28, 2024, the Supreme Court overturned the Chevron doctrine with its decision in Loper Bright Enterprises v. Raimondo. Under Chevron, courts have historically deferred to a federal agency’s interpretation of ambiguity in statutes that the agency administers. Courts premised Chevron deference on the notion that Congress implicitly delegated the interpretation to the agency.
In contrast, Loper Bright rejects Chevron’s assumption of implicit delegation: “When the best … Read the rest
For healthcare providers and practitioners, the rules surrounding non-competition agreements have evolved rapidly over the last two years, and that evolution accelerated even more this month. Over the past 18 months, states and the federal government enacted several new laws that substantially limit when healthcare entities can enforce non-competes. Then, on April 24, the Federal Trade Commission issued a rule that will bar most non-competes in the U.S. if it survives legal challenges (albeit no sooner than late August 2024). … Read the rest
Share
The Relist Watch column examines cert petitions that the Supreme Court has “relisted” for its upcoming conference. A short explanation of relists is available here.
Since our last installment, the Supreme Court has continued slowly chipping away at the still-sizable number of lingering relists from the end-of-summer “long conference.” The court denied review in five-time relist Johnson v. Prentice, involving an Illinois prisoner’s claim that his nearly three-year term of solitary confinement constituted cruel and unusual … Read the rest